Potential value of EUS in pancreatic surveillance of VHL patients | Zendy

Sophie J. van Asselt | Zendy; Adrienne H. Brouwers | Zendy; Hendrik M. van Dullemen | Zendy; Eric J. van der Jagt | Zendy; Alfons H.H. Bongaerts | Zendy; Klaas Pieter Koopmans | Zendy; Ido P. Kema | Zendy; Bernard A. Zonnenberg | Zendy; Henri Timmers | Zendy; Wouter W. de Herder | Zendy; Wim J. Sluiter | Zendy; Elisabeth G.E. de Vries | Zendy; Thera P. Links | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Potential value of EUS in pancreatic surveillance of VHL patients

Author(s) -

Sophie J. van Asselt,

Adrienne H. Brouwers,

Hendrik M. van Dullemen,

Eric J. van der Jagt,

Alfons H.H. Bongaerts,

Klaas Pieter Koopmans,

Ido P. Kema,

Bernard A. Zonnenberg,

Henri Timmers,

Wouter W. de Herder,

Wim J. Sluiter,

Elisabeth G.E. de Vries,

Thera P. Links

Publication year - 2016

Publication title -

european journal of endocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.897

H-Index - 148

eISSN - 1479-683X

pISSN - 0804-4643

DOI - 10.1530/eje-15-1012

Subject(s) - medicine , endoscopic ultrasound , magnetic resonance imaging , radiology , positron emission tomography , pancreas , neuroendocrine tumors , nuclear medicine

Patients with von Hippel-Lindau (VHL) disease are prone to develop pancreatic neuroendocrine tumors (pNETs). However, the best imaging technique for early detection of pNETs in VHL is currently unknown. In a head-to-head comparison, we evaluated endoscopic ultrasound (EUS) and (11)C-5-hydroxytryptophan positron emission tomography ((11)C-5-HTP PET) compared with conventional screening techniques for early detection of pancreatic solid lesions in VHL patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research